I would like them to consider allowing Ceplene to be partnered in the USA as well as Europe. It seems that it would be more interesting to a potential partner with the resources to advance Ceplene worldwide. An NDA could have been expedited with someone having the Capital to advance Ceplene.
"...with so much potential and possible news why no body cares?"
Share price is not volatile, but creaping up slowly last month. In Sweden many people seems to "care", some from beside, others on the train. As always. :-)Epicept has one of the most active boards in Sweden, competing just with Ericsson. Saying this as a messure of intensity, nothing else. It is possible to invest a few million SEK because of the traded volume in Stockholm. I see no problem compaired to other junior stocks in Stockholm. That is important.
As everybody else states: News, not potential news, will move us further. The decision to make is if it is worth to miss the initial rise instead of, perhaps, gain in other stocks.
I've made my decision, given me a 50% gain under my first year with Epicept. The chance of getting at least the double outcome for the second year seems, as I see it, very good. It is harvest time this year.